| Literature DB >> 27753538 |
Francesca Bianchi1,2, Michele Sommariva1,2, Loris De Cecco3, Tiziana Triulzi2, Sandra Romero-Cordoba4, Elda Tagliabue2, Lucia Sfondrini1, Andrea Balsari1,2.
Abstract
The autoimmune regulator gene (AIRE) plays a fundamental role in tolerance by promoting the expression of tissue-specific antigens in medullary thymic epithelial cells (mTECs). Recently, AIRE expression was detected also in human keratinocytes and in tumors originating in stratified epithelia. Here, we tested whether AIRE is expressed in cancer cells. We analyzed AIRE expression in cancer cases from The Cancer Genome Atlas (TCGA) RNA-seq dataset and we found association with better outcome. AIRE protein expression was verified by immunohistochemistry in a cohort of 39 human breast cancer specimens and its prognostic relevance was confirmed in microarray-based gene expression data set NKI-295 and KM-Plotter. Both in the RNA-seq and gene expression datasets analyzed, AIRE expression was an independent strong prognostic factor for relapse-free survival (RFS), particularly in estrogen receptor-positive tumors. Enrichment of translation-related pathways was observed in AIRE-expressing tumors by Ingenuity Pathway Analysis and a significant increase of cells in G1 phase and activation of caspase cascades was induced by AIRE transfection in breast cancer luminal cell lines, suggesting that AIRE-induced over-translation of proteins lead to cycle arrest and apoptosis. These data are the first to identify AIRE expression in breast cancer and an association with prognosis.Entities:
Keywords: AIRE; Apoptosis; Breast Cancer; Cell-cycle arrest; TCGA; Transcription Factor
Mesh:
Substances:
Year: 2016 PMID: 27753538 PMCID: PMC5176139 DOI: 10.1080/15384101.2016.1241918
Source DB: PubMed Journal: Cell Cycle ISSN: 1551-4005 Impact factor: 4.534